The present invention relates to methods of improving cognition and treating or preventing cognitive impairment in a subject. These methods involve administering to a subject in need of cognitive improvement or to a subject having or at risk for developing impaired cognition a ligand which binds to the nicotinic acetylcholine receptor and improves cognition or treats or prevents cognitive impairment in the subject.
